ASX - By Stock
|
NEU |
Re:
Ann: Notification regarding unquoted securities - NEU
|
|
Agent-86
|
32 |
16K |
24 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
32
|
16K
|
24
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
Agent-86
|
77 |
37K |
3 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
77
|
37K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Agent-86
|
23K |
11M |
16 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
23K
|
11M
|
16
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Agent-86
|
31K |
15M |
23 |
18/01/24 |
18/01/24 |
Charts
|
31K
|
15M
|
23
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Notification regarding unquoted securities - IMU
|
|
Agent-86
|
40 |
9.7K |
12 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
40
|
9.7K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Notification regarding unquoted securities - IMU
|
|
Agent-86
|
40 |
9.7K |
4 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
40
|
9.7K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Agent-86
|
9.9K |
4.4M |
5 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
5
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Agent-86
|
31K |
15M |
4 |
14/01/24 |
14/01/24 |
Charts
|
31K
|
15M
|
4
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Agent-86
|
31K |
15M |
10 |
13/01/24 |
13/01/24 |
Charts
|
31K
|
15M
|
10
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Agent-86
|
31K |
15M |
7 |
12/01/24 |
12/01/24 |
Charts
|
31K
|
15M
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Agent-86
|
423 |
190K |
17 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
423
|
190K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Agent-86
|
423 |
190K |
19 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
423
|
190K
|
19
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Agent-86
|
423 |
190K |
24 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
423
|
190K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Agent-86
|
9.9K |
4.4M |
7 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
7
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
Agent-86
|
166 |
75K |
67 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
166
|
75K
|
67
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
Agent-86
|
166 |
75K |
16 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
166
|
75K
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Market Capitalisation is a Better Valuation Metric Than Share Price
|
|
Agent-86
|
100 |
62K |
35 |
30/12/23 |
30/12/23 |
ASX - By Stock
|
100
|
62K
|
35
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Application for quotation of securities - IMU
|
|
Agent-86
|
52 |
19K |
35 |
30/12/23 |
30/12/23 |
ASX - By Stock
|
52
|
19K
|
35
|
|
ASX - By Stock
|
NEU |
Re:
Market Capitalisation is a Better Valuation Metric Than Share Price
|
|
Agent-86
|
100 |
62K |
44 |
30/12/23 |
30/12/23 |
ASX - By Stock
|
100
|
62K
|
44
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Agent-86
|
23K |
11M |
68 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
23K
|
11M
|
68
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Agent-86
|
13K |
6.3M |
7 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
13K
|
6.3M
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Agent-86
|
13K |
6.3M |
14 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
13K
|
6.3M
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Bristol Myers to acquire Karuna for $14Billion
|
|
Agent-86
|
24 |
11K |
11 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
24
|
11K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Bristol Myers to acquire Karuna for $14Billion
|
|
Agent-86
|
24 |
11K |
7 |
26/12/23 |
26/12/23 |
ASX - By Stock
|
24
|
11K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Forecasts 2024
|
|
Agent-86
|
40 |
19K |
9 |
26/12/23 |
26/12/23 |
ASX - By Stock
|
40
|
19K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Agent-86
|
9.9K |
4.4M |
11 |
26/12/23 |
26/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
11
|
|
ASX - By Stock
|
RAC |
Re:
RAC and NEU
|
|
Agent-86
|
23 |
9.8K |
24 |
26/12/23 |
26/12/23 |
ASX - By Stock
|
23
|
9.8K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Agent-86
|
9.9K |
4.4M |
59 |
23/12/23 |
23/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
59
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Agent-86
|
9.9K |
4.4M |
14 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
Agent-86
|
208 |
85K |
31 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
208
|
85K
|
31
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
Agent-86
|
208 |
85K |
20 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
208
|
85K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Agent-86
|
315 |
155K |
14 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
315
|
155K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Agent-86
|
315 |
155K |
31 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
315
|
155K
|
31
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Agent-86
|
315 |
155K |
21 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
315
|
155K
|
21
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Agent-86
|
315 |
155K |
8 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
315
|
155K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Agent-86
|
315 |
155K |
37 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
315
|
155K
|
37
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Agent-86
|
315 |
155K |
46 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
315
|
155K
|
46
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Agent-86
|
315 |
155K |
30 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
315
|
155K
|
30
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Agent-86
|
31K |
15M |
11 |
15/12/23 |
15/12/23 |
Charts
|
31K
|
15M
|
11
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Agent-86
|
31K |
15M |
3 |
15/12/23 |
15/12/23 |
Charts
|
31K
|
15M
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Agent-86
|
23K |
11M |
2 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
23K
|
11M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Agent-86
|
315 |
155K |
38 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
155K
|
38
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Agent-86
|
315 |
155K |
42 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
155K
|
42
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Agent-86
|
9.9K |
4.4M |
35 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
35
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and NeoImmuneTech to Improve Cancer Treatments
|
|
Agent-86
|
96 |
45K |
12 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
96
|
45K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and NeoImmuneTech to Improve Cancer Treatments
|
|
Agent-86
|
96 |
45K |
34 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
96
|
45K
|
34
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-100 Ph1b results show excellent safety & efficacy in TCL
|
|
Agent-86
|
37 |
16K |
23 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
37
|
16K
|
23
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
Agent-86
|
1.5K |
629K |
16 |
10/12/23 |
10/12/23 |
ASX - By Stock
|
1.5K
|
629K
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Agent-86
|
9.9K |
4.4M |
15 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren completes enrolment in Pitt Hopkins Phase 2 trial
|
|
Agent-86
|
92 |
40K |
24 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
92
|
40K
|
24
|
|